Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.39 USD | -0.52% | -1.04% | +25.16% |
May. 13 | Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.16% | 11.84M | |
+45.21% | 56.65B | |
-6.58% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.00% | 26.75B | |
-21.59% | 19.03B | |
+0.13% | 12.28B | |
+23.49% | 12.26B | |
+27.81% | 12.04B |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Avalo Therapeutics : RBC Initiates Avalo Therapeutics With Outperform Rating, Speculative Risk Qualifier, Sets Price Target at $6